Md Kaykobad Hossain


SCIENTIFIC CAREER


Since 2024

PhD candidate at Department of Clinical Science, Faculty of Medicine, University of Bergen, Norway

2023 – 2024 Researcher at Department of Clinical Science, Faculty of Medicine, University of Bergen, Norway

2021 – 2023 Master in Biomedical Sciences, Faculty of Medicine, University of Bergen, Norway

2019 – 2021 Undergraduate Teaching Assistant, Department of Pharmacy, Brac University, Bangladesh

2015 – 2019 Bachelor in Pharmacy, Department of Pharmacy, Brac University, Bangladesh


PUBLICATIONS while in the lab


  1. Hossain MK, Unger L, Larsen U, Altankhuyag A, Legøy TA, Paulo JA, Vethe H, Ghila L. Mapping the initial effects of carcinogen-induced oncogenic transformation in the mouse bladder. Exp Cell Res. 2025 Feb 21:114452. doi: 10.1016/j.yexcr.2025.114452.

POSTER presentations


  • Md Kaykobad Hossain, Altanchimeg Altankhuyag, Thomas A. Legøy, Simona Chera, Luiza Ghila. Dynamic proteome profiling detects progressive alterations induced by BBN in the mouse bladder. The Nordic Developmental Biology Societies & Michael Sars Symposium Joint Meeting, 28-31 May 2024, Bergen, Norway
  • Md Kaykobad Hossain, Altanchimeg Altankhuyag, Thomas A. Legøy, Simona Chera, Luiza Ghila. Short-term BBN treatment alters the proteomic profile of mouse bladder. CCBIO’s 12th Annual Symposium, 14-15 May 2024, Solstrand, Norway
  • Md Kaykobad Hossain, Altanchimeg Altankhuyag, Thomas A. Legøy, Simona Chera, Luiza Ghila. “Mapping predictive bladder cancer signatures in a mouse model”. CCBIO’s 11th Annual Symposium, 8-10 May 2023, Solstrand, Norway

FUNDING


 

Agency logo Period Grant Description
2025-2026 Meltzer prosjektstipend: Deciphering the role of WNT4 in bladder cancer using patient-derived organoids
We plan to investigate the role of Wnt4 in the generation of PDOs, including an assessment of the tumorigenic ability of laboratory grown PDOs by injecting them into mice and by observing tumor formation.
2024-2028 PhD Project: Investigating cell transitions and predictive cancer signature in bladder urothelium
We plan to use complex genetic setups, patient derived organoids and multi-omics to dynamically characterize the switch from epithelial regeneration to tumorigenesis using bladder urothelium as a model.

 


Journal Club Posts


  1. Distinct Infiltration of T Cell Populations in Bladder Cancer Molecular Subtypes